Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
About this item
Full title
Author / Creator
Publisher
Waltham, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Waltham, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In this small, preliminary study of sofosbuvir, a nucleotide inhibitor of HCV polymerase, treatment with sofosbuvir and ribavirin, without peginterferon, was effective in achieving a sustained virologic response in patients with HCV genotype 1, 2, or 3 infection.
Recent progress in the treatment of chronic hepatitis C virus (HCV) infection — the...
Alternative Titles
Full title
Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1266235436
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1266235436
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1208953
